Assessment of vaccine testing at three laboratories using the guinea pig model of tuberculosis. 2012

Ajay Grover, and Jolynn Troudt, and Kimberly Arnett, and Linda Izzo, and Megan Lucas, and Katie Strain, and Christine McFarland, and Yper Hall, and David McMurray, and Ann Williams, and Karen Dobos, and Angelo Izzo
Colorado State University, Department of Microbiology, Immunology & Pathology, 1682 Campus Delivery, Fort Collins, CO 80523, USA.

The guinea pig model of tuberculosis is used extensively in different locations to assess the efficacy of novel tuberculosis vaccines during pre-clinical development. Two key assays are used to measure protection against virulent challenge: a 30 day post-infection assessment of mycobacterial burden and long-term post-infection survival and pathology analysis. To determine the consistency and robustness of the guinea pig model for testing vaccines, a comparative assessment between three sites that are currently involved in testing tuberculosis vaccines from external providers was performed. Each site was asked to test two "subunit" type vaccines in their routine animal model as if testing vaccines from a provider. All sites performed a 30 day study, and one site also performed a long-term survival/pathology study. Despite some differences in experimental approach between the sites, such as the origin of the Mycobacterium tuberculosis strain and the type of aerosol exposure device used to infect the animals and the source of the guinea pigs, the data obtained between sites were consistent in regard to the ability of each "vaccine" tested to reduce the mycobacterial burden. The observations also showed that there was good concurrence between the results of short-term and long-term studies. This validation exercise means that efficacy data can be compared between sites.

UI MeSH Term Description Entries
D009169 Mycobacterium tuberculosis A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation. Mycobacterium tuberculosis H37Rv
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014376 Tuberculosis Any of the infectious diseases of man and other animals caused by species of MYCOBACTERIUM TUBERCULOSIS. Koch's Disease,Kochs Disease,Mycobacterium tuberculosis Infection,Infection, Mycobacterium tuberculosis,Infections, Mycobacterium tuberculosis,Koch Disease,Mycobacterium tuberculosis Infections,Tuberculoses
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D032581 Tuberculosis Vaccines Vaccines or candidate vaccines used to prevent or treat TUBERCULOSIS. Tuberculosis Vaccine,Vaccine, Tuberculosis,Vaccines, Tuberculosis

Related Publications

Ajay Grover, and Jolynn Troudt, and Kimberly Arnett, and Linda Izzo, and Megan Lucas, and Katie Strain, and Christine McFarland, and Yper Hall, and David McMurray, and Ann Williams, and Karen Dobos, and Angelo Izzo
January 2005, Tuberculosis (Edinburgh, Scotland),
Ajay Grover, and Jolynn Troudt, and Kimberly Arnett, and Linda Izzo, and Megan Lucas, and Katie Strain, and Christine McFarland, and Yper Hall, and David McMurray, and Ann Williams, and Karen Dobos, and Angelo Izzo
January 2005, Tuberculosis (Edinburgh, Scotland),
Ajay Grover, and Jolynn Troudt, and Kimberly Arnett, and Linda Izzo, and Megan Lucas, and Katie Strain, and Christine McFarland, and Yper Hall, and David McMurray, and Ann Williams, and Karen Dobos, and Angelo Izzo
January 1999, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease,
Ajay Grover, and Jolynn Troudt, and Kimberly Arnett, and Linda Izzo, and Megan Lucas, and Katie Strain, and Christine McFarland, and Yper Hall, and David McMurray, and Ann Williams, and Karen Dobos, and Angelo Izzo
December 2021, Current protocols,
Ajay Grover, and Jolynn Troudt, and Kimberly Arnett, and Linda Izzo, and Megan Lucas, and Katie Strain, and Christine McFarland, and Yper Hall, and David McMurray, and Ann Williams, and Karen Dobos, and Angelo Izzo
March 2017, Vaccine,
Ajay Grover, and Jolynn Troudt, and Kimberly Arnett, and Linda Izzo, and Megan Lucas, and Katie Strain, and Christine McFarland, and Yper Hall, and David McMurray, and Ann Williams, and Karen Dobos, and Angelo Izzo
April 2003, Infection and immunity,
Ajay Grover, and Jolynn Troudt, and Kimberly Arnett, and Linda Izzo, and Megan Lucas, and Katie Strain, and Christine McFarland, and Yper Hall, and David McMurray, and Ann Williams, and Karen Dobos, and Angelo Izzo
August 2003, International immunology,
Ajay Grover, and Jolynn Troudt, and Kimberly Arnett, and Linda Izzo, and Megan Lucas, and Katie Strain, and Christine McFarland, and Yper Hall, and David McMurray, and Ann Williams, and Karen Dobos, and Angelo Izzo
December 2010, Antimicrobial agents and chemotherapy,
Ajay Grover, and Jolynn Troudt, and Kimberly Arnett, and Linda Izzo, and Megan Lucas, and Katie Strain, and Christine McFarland, and Yper Hall, and David McMurray, and Ann Williams, and Karen Dobos, and Angelo Izzo
January 2005, Tuberculosis (Edinburgh, Scotland),
Ajay Grover, and Jolynn Troudt, and Kimberly Arnett, and Linda Izzo, and Megan Lucas, and Katie Strain, and Christine McFarland, and Yper Hall, and David McMurray, and Ann Williams, and Karen Dobos, and Angelo Izzo
January 2008, Microbes and infection,
Copied contents to your clipboard!